John R Burnett

17PUBLICATIONS
2CO-AUTHORS
Gene and molecular therapyBiomolecular modelling and designAstroparticle physics and particle cosmologyCharacterisation of biological macromoleculesAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 19, 2026
Injectable, oral, gene-based, and vaccine-driven PCSK9-targeted therapies: emerging clinical insights shaping the future of hypercholesterolemia management.

|Apr 03, 2026
ANGPTL3 gene editing with CRISPR-Cas9: early trial insights.

Xuan L Tang, Amanda J Hooper, John R Burnett

|Nov 29, 2025
Assessing the clinical development of zerlasiran, a small-interfering RNA for elevated lipoprotein(a).

Xuan L Tang, Amanda J Hooper, John R Burnett

|Nov 10, 2025
Assessing the clinical progress of muvalaplin for reducing lipoprotein(a).

Amanda J Hooper, P Mihika S Fernando, John R Burnett

|Oct 03, 2025
Emerging ANGPTL3-directed therapies for hyperlipidemia: insights from two recent phase II trials.

Amanda J Hooper, Thusyanthy Parameswaran, John R Burnett

|Aug 08, 2025
Lomitapide for the treatment of pediatric homozygous familial hypercholesterolemia.

Amanda J Hooper, Damon A Bell, John R Burnett

Pageof 3

Frequent Collaborators

2 joint publications

Robert A Hegele

1 joint publications

Kavinda Dayasiri